CN111513925B - High-strength waterproof breathable composite dressing and preparation method thereof - Google Patents
High-strength waterproof breathable composite dressing and preparation method thereof Download PDFInfo
- Publication number
- CN111513925B CN111513925B CN202010394009.0A CN202010394009A CN111513925B CN 111513925 B CN111513925 B CN 111513925B CN 202010394009 A CN202010394009 A CN 202010394009A CN 111513925 B CN111513925 B CN 111513925B
- Authority
- CN
- China
- Prior art keywords
- hydrogel
- composite dressing
- dressing
- wound
- film
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000002131 composite material Substances 0.000 title claims abstract description 50
- 238000002360 preparation method Methods 0.000 title abstract description 19
- 239000011148 porous material Substances 0.000 claims abstract description 14
- 239000000017 hydrogel Substances 0.000 claims description 80
- -1 polytetrafluoroethylene Polymers 0.000 claims description 49
- 229920001343 polytetrafluoroethylene Polymers 0.000 claims description 44
- 239000004810 polytetrafluoroethylene Substances 0.000 claims description 44
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 24
- 239000012528 membrane Substances 0.000 claims description 21
- 150000001875 compounds Chemical class 0.000 claims description 20
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 18
- 238000013329 compounding Methods 0.000 claims description 16
- 239000008367 deionised water Substances 0.000 claims description 13
- 229910021641 deionized water Inorganic materials 0.000 claims description 13
- 238000002791 soaking Methods 0.000 claims description 11
- 239000000178 monomer Substances 0.000 claims description 10
- 239000004372 Polyvinyl alcohol Substances 0.000 claims description 9
- 239000007864 aqueous solution Substances 0.000 claims description 9
- 239000011248 coating agent Substances 0.000 claims description 9
- 238000000576 coating method Methods 0.000 claims description 9
- 229910052757 nitrogen Inorganic materials 0.000 claims description 9
- 229920002451 polyvinyl alcohol Polymers 0.000 claims description 9
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 8
- 239000001301 oxygen Substances 0.000 claims description 8
- 229910052760 oxygen Inorganic materials 0.000 claims description 8
- 229920002818 (Hydroxyethyl)methacrylate Polymers 0.000 claims description 7
- WOBHKFSMXKNTIM-UHFFFAOYSA-N Hydroxyethyl methacrylate Chemical compound CC(=C)C(=O)OCCO WOBHKFSMXKNTIM-UHFFFAOYSA-N 0.000 claims description 7
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 claims description 7
- 239000004820 Pressure-sensitive adhesive Substances 0.000 claims description 7
- 238000004140 cleaning Methods 0.000 claims description 6
- 229920001477 hydrophilic polymer Polymers 0.000 claims description 6
- 239000003999 initiator Substances 0.000 claims description 6
- 230000001678 irradiating effect Effects 0.000 claims description 6
- 239000002994 raw material Substances 0.000 claims description 6
- CERQOIWHTDAKMF-UHFFFAOYSA-N Methacrylic acid Chemical compound CC(=C)C(O)=O CERQOIWHTDAKMF-UHFFFAOYSA-N 0.000 claims description 5
- 125000004386 diacrylate group Chemical group 0.000 claims description 5
- 238000000034 method Methods 0.000 claims description 5
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 claims description 4
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 claims description 4
- HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 claims description 4
- 239000002202 Polyethylene glycol Substances 0.000 claims description 4
- 230000004913 activation Effects 0.000 claims description 4
- 239000007789 gas Substances 0.000 claims description 4
- 229920001223 polyethylene glycol Polymers 0.000 claims description 4
- 238000007348 radical reaction Methods 0.000 claims description 4
- 150000003254 radicals Chemical class 0.000 claims description 4
- 229920002845 Poly(methacrylic acid) Polymers 0.000 claims description 3
- 239000003431 cross linking reagent Substances 0.000 claims description 3
- 238000005520 cutting process Methods 0.000 claims description 3
- 229920002521 macromolecule Polymers 0.000 claims description 3
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 claims description 2
- 230000009471 action Effects 0.000 claims description 2
- 230000003213 activating effect Effects 0.000 claims description 2
- 229920002674 hyaluronan Polymers 0.000 claims description 2
- 229960003160 hyaluronic acid Drugs 0.000 claims description 2
- 238000002955 isolation Methods 0.000 claims description 2
- 230000001706 oxygenating effect Effects 0.000 claims description 2
- 238000004806 packaging method and process Methods 0.000 claims description 2
- 238000007789 sealing Methods 0.000 claims description 2
- 230000002194 synthesizing effect Effects 0.000 claims description 2
- 238000005406 washing Methods 0.000 claims description 2
- 238000010382 chemical cross-linking Methods 0.000 claims 1
- 150000002734 metacrylic acid derivatives Chemical class 0.000 claims 1
- 229920000642 polymer Polymers 0.000 claims 1
- 150000003384 small molecules Chemical class 0.000 claims 1
- 206010052428 Wound Diseases 0.000 abstract description 51
- 208000027418 Wounds and injury Diseases 0.000 abstract description 51
- 229920000295 expanded polytetrafluoroethylene Polymers 0.000 abstract description 27
- 210000000416 exudates and transudate Anatomy 0.000 abstract description 12
- 241000894006 Bacteria Species 0.000 abstract description 7
- 210000004243 sweat Anatomy 0.000 abstract description 6
- 206010048038 Wound infection Diseases 0.000 abstract description 5
- 230000003373 anti-fouling effect Effects 0.000 abstract description 5
- 230000000149 penetrating effect Effects 0.000 abstract 1
- 210000004379 membrane Anatomy 0.000 description 16
- 239000000243 solution Substances 0.000 description 14
- 239000003570 air Substances 0.000 description 12
- 230000035699 permeability Effects 0.000 description 11
- 239000000463 material Substances 0.000 description 6
- 230000004048 modification Effects 0.000 description 5
- 238000012986 modification Methods 0.000 description 5
- 229920000058 polyacrylate Polymers 0.000 description 5
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 5
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 5
- 238000010008 shearing Methods 0.000 description 5
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 4
- 210000002469 basement membrane Anatomy 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 238000002203 pretreatment Methods 0.000 description 4
- 230000000844 anti-bacterial effect Effects 0.000 description 3
- 239000011521 glass Substances 0.000 description 3
- 230000035876 healing Effects 0.000 description 3
- 230000002209 hydrophobic effect Effects 0.000 description 3
- 230000029663 wound healing Effects 0.000 description 3
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- 150000001336 alkenes Chemical class 0.000 description 2
- 229910052786 argon Inorganic materials 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 230000007547 defect Effects 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 239000004744 fabric Substances 0.000 description 2
- 230000002349 favourable effect Effects 0.000 description 2
- 239000005357 flat glass Substances 0.000 description 2
- 238000007654 immersion Methods 0.000 description 2
- 239000011368 organic material Substances 0.000 description 2
- 239000004814 polyurethane Substances 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 229920001661 Chitosan Polymers 0.000 description 1
- CERQOIWHTDAKMF-UHFFFAOYSA-M Methacrylate Chemical compound CC(=C)C([O-])=O CERQOIWHTDAKMF-UHFFFAOYSA-M 0.000 description 1
- 239000011837 N,N-methylenebisacrylamide Substances 0.000 description 1
- 239000004952 Polyamide Substances 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- 238000005411 Van der Waals force Methods 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 239000000356 contaminant Substances 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 239000003344 environmental pollutant Substances 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 229910052734 helium Inorganic materials 0.000 description 1
- 239000001307 helium Substances 0.000 description 1
- SWQJXJOGLNCZEY-UHFFFAOYSA-N helium atom Chemical compound [He] SWQJXJOGLNCZEY-UHFFFAOYSA-N 0.000 description 1
- 238000011065 in-situ storage Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- ZIUHHBKFKCYYJD-UHFFFAOYSA-N n,n'-methylenebisacrylamide Chemical compound C=CC(=O)NCNC(=O)C=C ZIUHHBKFKCYYJD-UHFFFAOYSA-N 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 239000012466 permeate Substances 0.000 description 1
- 231100000719 pollutant Toxicity 0.000 description 1
- 229920002647 polyamide Polymers 0.000 description 1
- 229920000151 polyglycol Polymers 0.000 description 1
- 239000010695 polyglycol Substances 0.000 description 1
- 229920002635 polyurethane Polymers 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 150000003242 quaternary ammonium salts Chemical class 0.000 description 1
- 238000010526 radical polymerization reaction Methods 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000004381 surface treatment Methods 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 238000004804 winding Methods 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F13/00987—Apparatus or processes for manufacturing non-adhesive dressings or bandages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F13/01—Non-adhesive bandages or dressings
- A61F13/01008—Non-adhesive bandages or dressings characterised by the material
- A61F13/01017—Non-adhesive bandages or dressings characterised by the material synthetic, e.g. polymer based
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F13/01—Non-adhesive bandages or dressings
- A61F13/01021—Non-adhesive bandages or dressings characterised by the structure of the dressing
- A61F13/01029—Non-adhesive bandages or dressings characterised by the structure of the dressing made of multiple layers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F13/01—Non-adhesive bandages or dressings
- A61F13/01034—Non-adhesive bandages or dressings characterised by a property
- A61F13/01046—Air-vapor permeability
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/20—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing organic materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
- A61L15/24—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
- A61L15/26—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/42—Use of materials characterised by their function or physical properties
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/42—Use of materials characterised by their function or physical properties
- A61L15/425—Porous materials, e.g. foams or sponges
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/42—Use of materials characterised by their function or physical properties
- A61L15/46—Deodorants or malodour counteractants, e.g. to inhibit the formation of ammonia or bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/42—Use of materials characterised by their function or physical properties
- A61L15/52—Water-repellants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F2013/00089—Wound bandages
- A61F2013/00187—Wound bandages insulating; warmth or cold applying
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F2013/00089—Wound bandages
- A61F2013/00246—Wound bandages in a special way pervious to air or vapours
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F2013/00089—Wound bandages
- A61F2013/00314—Wound bandages with surface treatments
- A61F2013/00319—Wound bandages with surface treatments to make surface hydrophobic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F2013/00361—Plasters
- A61F2013/00727—Plasters means for wound humidity control
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/412—Tissue-regenerating or healing or proliferative agents
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Hematology (AREA)
- Materials Engineering (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Manufacturing & Machinery (AREA)
- Dispersion Chemistry (AREA)
- Materials For Medical Uses (AREA)
Abstract
The invention discloses a high-strength waterproof breathable composite dressing and a preparation method thereof. The composite dressing prepared by the invention adopts the expanded polytetrafluoroethylene film as an outer layer structure, so that the dressing has good waterproof and antifouling performances, and the special pore structure can effectively prevent bacteria from penetrating into a wound and effectively prevent wound infection; meanwhile, wound exudate and sweat on the skin can be rapidly evaporated through the special pore structure, and the composite dressing keeps the excellent performance of expanded polytetrafluoroethylene, so that the dressing can meet the requirements of wound treatment under complex conditions in battlefields and fields.
Description
Technical Field
The invention relates to the technical field of medical dressings, in particular to a high-strength waterproof breathable composite dressing and a preparation method thereof.
Background
Traditional surgery covers the wound with gauze, but the gauze needs to be replaced every few hours before the wound becomes scabbed. And the yarn is easy to adhere to the wound, so that the wound is easy to be secondarily damaged during replacement, a chronic wound is formed, healing is delayed, and even the life is possibly threatened. For this purpose, hydrogel dressings have been developed for modern medicine to cover the wound directly, the inner layer of which is often a hydrogel that promotes wound healing and adheres directly to the skin, and the outer layer of which is a nonwoven or polyurethane fabric. Has good air permeability, but the material has poor water resistance and does not have the capability of isolating bacteria.
The wound can be polluted by rainwater, muddy water, blood and the like at any time after being treated in the fields such as battlefields, fields and the like, and pollutants such as soil and the like are easily adhered to the surface of the dressing. Bacteria in these contaminants are easily penetrated to cause wound infection. The surface treatment is carried out on the dressing, so that the waterproofness of the dressing can be effectively improved, but the waterproof coating can reduce the air permeability of the dressing, and wound exudate and sweat cannot be quickly discharged to influence the healing of the wound. Therefore, the novel wound dressing which has high waterproof capacity, can resist the pollution of other dirt and can quickly discharge wound exudate and sweat has important practical significance for battlefield and field rescue.
In the prior art, although polytetrafluoroethylene has good waterproofness and air permeability and is an ideal waterproof material, hydrogel is also commonly used as an inner layer material of a wound dressing, but the polytetrafluoroethylene has extremely low surface energy and a contact angle with water of more than 140 degrees, so that the polytetrafluoroethylene cannot be effectively combined with hydrogel called solid water. Patent CN201810087777.4 discloses a preparation method of medical hydrogel capable of being eluted and hydrogel dressing thereof, wherein although polytetrafluoroethylene film is also used as a base material, the hydrogel and the base material are bonded together by using a tackifier, and the addition of the tackifier can block the pore channels of the polytetrafluoroethylene film, so that the dressing prepared in this way has the defect of poor air permeability. Therefore, to realize the preparation of the high-strength waterproof and breathable dressing, the effective connection between the two must be realized.
Disclosure of Invention
Aiming at the defects in the prior art, the invention aims to provide a high-strength waterproof breathable composite dressing to solve the technical problem that the breathable effect is affected by using a tackifier to connect polytetrafluoroethylene and hydrogel in the prior art.
The invention also provides a method for preparing the composite dressing, which aims to solve the technical problem that the combination of the polytetrafluoroethylene and the hydrogel is difficult.
In order to achieve the purpose, the technical scheme adopted by the invention is as follows:
the utility model provides a waterproof ventilative composite dressing of excelling in, includes skin and inlayer, and the skin is the polytetrafluoroethylene film, and the inlayer is aquogel, the polytetrafluoroethylene film has mesh structure, the polytetrafluoroethylene film links to each other through grafting hydrophilic macromolecular compound and inlayer aquogel complex.
The outer layer of the invention adopts the polytetrafluoroethylene film prepared by the biaxial tension process, the polytetrafluoroethylene film after the treatment has a uniform mesh structure, then the surface of the polytetrafluoroethylene film is activated by plasma, then the free radical reaction is directly initiated on the surface of the polytetrafluoroethylene film, the hydrophilic high molecular monomer containing double bonds is grafted, after the modification, the surface of the polytetrafluoroethylene film is changed from super hydrophobicity to hydrophilicity, and a layer of villous hydrophilic high molecular chain grows on the surface of the polytetrafluoroethylene film, thus being more beneficial to compounding with hydrogel. Meanwhile, only one side of the polytetrafluoroethylene film is modified, the unmodified side still has higher hydrophobicity, and the mesh structure is not damaged, so that the composite dressing has good waterproof, antifouling, antibacterial and breathable performances.
Further, the polytetrafluoroethylene film is obtained through expansion and biaxial stretching, and the average pore diameter of the pore channel structure on the polytetrafluoroethylene film is less than 0.5 μm. The polytetrafluoroethylene film adopted by the invention can form a uniform mesh structure after being puffed and processed by biaxial stretching, and the aperture of the mesh structure is far smaller than the diameter of bacteria, so that the bacteria can be prevented from permeating, the wound infection can be prevented, and the polytetrafluoroethylene film is very suitable for the requirements of complex scenes such as battlefields, field rescue and the like.
Furthermore, the porosity of the polytetrafluoroethylene film is more than 90%, and the thickness of the polytetrafluoroethylene film is 20-500 microns. The porosity of the polytetrafluoroethylene film reaches more than 90 percent, and the polytetrafluoroethylene film has higher porosity and good air permeability.
Further, the hydrogel includes a PVA hydrogel, a hydroxyethyl methacrylate hydrogel, a polymethacrylic acid hydrogel or a polyethylene glycol diacrylate hydrogel. The hydrogel meets medical requirements, the hydrogel in the inner layer can reduce the temperature of a wound, reduce pain of the wound, keep the wound moist, promote the wound to grow, effectively absorb wound exudates, discharge the wound exudates through a surface film, and have certain antibacterial capacity, so that the infection of the wound can be effectively avoided.
Further, the hydrophilic polymer compound includes acrylamide, methylene acrylamide, acrylic acid, methacrylic acid, vinyl pyrrolidone, or a methacrylate-based compound. The hydrophilic high molecular compounds are grafted on the surface of the polytetrafluoroethylene film by initiating free radical reaction on the surface of the polytetrafluoroethylene film, and the hydrophilic high molecular compounds are used as templates, so that the hydrogel which is favorable for wound healing can grow on the surface of the polytetrafluoroethylene film and is well connected with the polytetrafluoroethylene film, and the hydrophilic high molecular compounds have strong hydrophilicity, cannot block pore channels of the hydrophobic polytetrafluoroethylene film, and enable the composite dressing to have good air permeability.
A preparation method of a high-strength waterproof breathable composite dressing comprises the following steps:
(1) and (3) activation: selecting a polytetrafluoroethylene film with a pore structure, cutting, activating for 10-300 s by a vacuum plasma cleaning machine, adjusting the flow of plasma gas to 10-100 mL/min, and controlling a vacuum system to keep the vacuum degree at 0.01-0.1 MPa to obtain an activated base film. Wherein the plasma generation frequency is 100kHz-40MHz, and the introduced plasma generation gas can be one of nitrogen, argon, helium, carbon dioxide or air; the activation is carried out for 20-200 s preferably by a vacuum plasma cleaning machine, and the vacuum degree of the vacuum system is controlled to be 0.08-0.095 MPa preferably.
(2) Grafting: and (3) putting the activated base membrane into an aqueous solution containing a hydrophilic high molecular compound, introducing nitrogen for 5-10 min to remove oxygen, and irradiating the surface of one side of the activated base membrane soaked in the aqueous solution for 5-10 h by using an ultraviolet lamp. Wherein the ultraviolet lamp adopts a 365nm ultraviolet lamp for irradiation.
(3) Cleaning: and (3) transferring the base film treated in the step (2) into deionized water to be soaked for 12-48 h, replacing the deionized water for three times during soaking, and washing away unreacted compounds on the surface of the base film.
(4) Compounding: and (4) transferring the base membrane treated in the step (3) into a clamp, sequentially adding raw materials of hydrogel into a mold in the clamp, and synthesizing and growing the hydrogel on the grafted side surface of the activated base membrane to be compounded with the base membrane. Wherein, one side of the basement membrane treated in the step (3) is grafted with a hydrophilic high molecular compound, the basement membrane is placed in a special hydrogel clamp, the grafted side is contacted with the raw material of the hydrogel, and the hydrogel grows on the surface of the grafted side of the basement membrane in the synthesis process, so that the synthesized hydrogel can be well connected with the polytetrafluoroethylene membrane.
(5) And (3) post-treatment: taking out the base film after the hydrogel is cured, coating pressure-sensitive adhesive on the blank area around the hydrogel on the base film, pasting isolation paper on the back of the base film, and sealing and packaging to obtain the novel dressing.
Further, the concentration of the hydrophilic polymer compound in the aqueous solution of the hydrophilic polymer compound in the step (2) is 0.2 to 5 mol/L.
Further, raw materials for preparing the hydrogel are one or more of monomers of acrylamide, methylene acrylamide, acrylic acid, methacrylic acid or hydroxyethyl methacrylate; or the raw material for preparing the hydrogel is one or more of a plurality of high molecular compounds of hyaluronic acid, polyvinyl alcohol or polyethylene glycol diacrylate.
Further, the hydrogel is synthesized by a small molecular monomer through a free radical reaction under the action of a cross-linking agent and an initiator.
Further, the hydrogel is prepared by physically or chemically crosslinking a high molecular compound.
The high-strength waterproof breathable composite dressing prepared by the preparation method has the following characteristics:
1. the expanded polytetrafluoroethylene film is activated by a low-temperature plasma technology, and a layer of villous hydrophilic macromolecules grows on the activated surface of the expanded polytetrafluoroethylene film in a free radical polymerization mode, so that the surface of the modified expanded polytetrafluoroethylene film is changed from super-hydrophobicity to hydrophilicity, and the modified expanded polytetrafluoroethylene film is more favorable for being compounded with hydrogel.
2. Because only the single-side modification is carried out on the expanded polytetrafluoroethylene film, the unmodified side still has very high hydrophobicity, meanwhile, the reticular structure is not damaged, and the reticular structure on the modified side can allow sweat and wound exudate on the skin at the wound to permeate in a molecular form, so that the sweat and the wound exudate on the skin at the wound are discharged in time, the liquid deposition at the wound is reduced, the wound surface is kept clean, and the wound healing is promoted; the unmodified surface still has good hydrophobicity, so that the penetration of external liquid can be effectively prevented, and the net structure can prevent bacteria from extending into a wound to prevent wound infection, so that the composite dressing can meet the requirements of complex scene application in battlefields and field rescue.
3. The inner layer is hydrogel meeting medical requirements and has the following characteristics:
1) the temperature of the wound can be reduced, and the pain feeling of the wound can be reduced;
2) can keep the wound moist and promote the wound growth;
3) the wound exudate can be effectively absorbed and discharged through the surface film;
4) has certain antibacterial ability and can effectively avoid wound infection.
Compared with the prior art, the invention has the following beneficial effects:
1. the composite dressing prepared by the invention adopts expanded polytetrafluoroethyleneThe alkene film is used as an outer layer structure, the surface of the outer layer structure has a water contact angle as high as 135 degrees, the alkene film is hydrophobic, liquid is not easy to wet the outer layer structure and easily moves on the outer surface of the outer layer structure, so that the composite dressing has good waterproof and antifouling properties, and the outer layer structure has a uniform mesh structure and can effectively prevent bacteria from entering a wound and prevent the wound from being infected; meanwhile, wound exudate and sweat on the skin can be rapidly evaporated through the mesh structure, the composite dressing has excellent air permeability and capability of absorbing exudate, and the air permeability reaches 10000 g.m-2·24h-1The liquid absorption and seepage capacity is 40 g.100 cm-2And the expansion rate of the thickness of the hydrogel layer is lower than 5 percent when the hydrogel layer is soaked in water, so that the composite dressing cannot deform when in use, the excellent performance of the expanded polytetrafluoroethylene is kept, and the dressing can meet the requirements of wound treatment under complex conditions in battlefields and fields; the hydrogel adopted in the inner layer can effectively reduce the temperature of the wound to relieve the pain of the wound, the wound cannot be adhered, meanwhile, the moist environment can also promote the healing of the wound, the exudate of the wound can be absorbed, and the exudate is discharged through the pore structure of the outer layer film.
2. The preparation method of the invention activates the surface of the expanded polytetrafluoroethylene film by using plasma, realizes the high-efficiency compounding between the similar expanded polytetrafluoroethylene and the hydrogel in a mode of in-situ growth on the activated surface, ensures the waterproof and antifouling performances of the surface of the expanded polytetrafluoroethylene, and also provides a new idea for compounding the expanded polytetrafluoroethylene and other materials.
Drawings
Fig. 1 is a schematic structural diagram of a high-strength waterproof breathable composite dressing.
Fig. 2 is a photograph of the prepared wound dressing.
Fig. 3 is a contact angle of the surface of the dressing of fig. 1.
In the figure: an outer layer 1 and an inner layer 2.
Detailed Description
The present invention will be described in further detail with reference to specific examples.
High-strength waterproof breathable composite dressing
Referring to fig. 1, the high-strength waterproof breathable composite dressing comprises an outer layer and an inner layer, wherein the outer layer is a polytetrafluoroethylene film, the inner layer is hydrogel, the polytetrafluoroethylene film is a biaxially oriented polytetrafluoroethylene film and has a uniform mesh structure, and the polytetrafluoroethylene film is connected with the hydrogel of the inner layer in a composite mode through grafting a hydrophilic high molecular compound. In actual use, the polytetrafluoroethylene film may be coated with an organic material film on the outer surface, i.e., the surface on the side not activated, and the organic material film such as polyamide, PU, PP cloth may be hot-pressed and laminated on the side surface, so that the strength of the polytetrafluoroethylene film can be improved after coating.
TABLE 1 major Components of a high-strength, waterproof, breathable composite dressing
Second, preparation method of high-strength waterproof breathable composite dressing
Example 1: composition of expanded polytetrafluoroethylene and PVA hydrogel
(1) And (3) activation: selecting a 150-micron-thick double-drawn expanded polytetrafluoroethylene film with the pore diameter of 0.1 micron, and cutting the film into a square shape with the thickness of 10cmx10 cm; fixing the expanded polytetrafluoroethylene film on plate glass, and putting the plate glass into a vacuum plasma generation bin with the frequency of 20 MHz; vacuumizing, introducing argon gas flow of 20mL/min, adjusting the power of equipment to be 115w, controlling the vacuum degree of a system to be 0.095MPa, and treating plasma for 100 s.
(2) Grafting: immediately transferring the membrane into a special mould, adding 1mol/L of vinyl pyrrolidone aqueous solution, introducing nitrogen to remove oxygen, and transferring to an ultraviolet lamp for irradiation grafting for 6 h.
(3) Cleaning: the membrane is immersed in deionized water, and water is changed every 8 hours for 24 hours.
(4) Compounding: transferring the cleaned basement membrane to a professional hydrogel fixture, adding 10% PVA aqueous solution (wherein the mass fraction of the quaternary ammonium salt chitosan is 5 wt%), pouring the aqueous solution into a glass mold, introducing nitrogen to remove oxygen, freezing the glass mold in a refrigerator at 18 ℃ below zero, and then unfreezing the glass mold.
(5) And (3) post-treatment: coating polyacrylate pressure-sensitive adhesive on the edge position which is not covered with hydrogel, attaching release paper, and shearing to obtain the required wound composite dressing.
Wherein, the polyvinyl alcohol solution can be better spread on the surface of the expanded polytetrafluoroethylene film after grafting modification, and the polyvinyl alcohol solution is solidified by a freezing-melting method to form hydrogel. Through physical winding and van der waals force between polyvinyl alcohol and polyvinylpyrrolidone, effective compounding of hydrogel and the expanded polytetrafluoroethylene film is achieved, and the technical problem that the compounding effect of finished hydrogel and the expanded polytetrafluoroethylene film is poor in the prior art is solved.
Example 2: compounding of expanded polytetrafluoroethylene and hydroxyethyl methacrylate hydrogel
In example 2, the pretreatment method for the expanded polytetrafluoroethylene membrane was the same as in example 1, except that the preparation of the hydrogel, that is, step (4), was different.
(4) Compounding: the plasma activated and PVP grafted base membrane was transferred to a hydrogel preparation jig. Preparing 1mol/L hydroxyethyl methacrylate solution, and adding a crosslinking agent N, N-methylene bisacrylamide (the concentration is 1mol percent of the monomer concentration) and an initiator alpha-glutaric acid (the concentration is 0.1 mol percent of the monomer concentration). And introducing nitrogen into the solution to remove oxygen, transferring the solution into a mold with a base film, and irradiating for 12 hours under 365nm ultraviolet light. Taking out and soaking in deionized water for 24h, and replacing the deionized water for three times during the soaking period to prepare the composite hydrogel.
(5) And (3) post-treatment: coating polyacrylate pressure-sensitive adhesive on the edge position which is not covered with hydrogel, attaching release paper, and shearing to obtain the required wound composite dressing.
Example 3: compounding expanded polytetrafluoroethylene with polymethacrylic acid hydrogel
In example 3, the pretreatment method for the expanded polytetrafluoroethylene membrane was the same as in example 1, except that the preparation of the hydrogel, that is, step (4), was different.
(4) Compounding: the plasma activated and PVP grafted base membrane was transferred to a hydrogel preparation jig. A methacrylic acid solution having a concentration of 1mol/L was prepared, and an initiator a-glutaric acid (concentration: 0.1 mol% based on the monomer concentration) was added thereto. And introducing nitrogen into the solution to remove oxygen, transferring the solution into a mold with a base film, and irradiating for 12 hours under 365nm ultraviolet light. Taking out and soaking in deionized water for 24h, and replacing the deionized water for three times during the soaking period to prepare the composite hydrogel.
(5) And (3) post-treatment: coating polyacrylate pressure-sensitive adhesive on the edge position which is not covered with hydrogel, attaching release paper, and shearing to obtain the required wound composite dressing.
Example 4: compounding expanded polytetrafluoroethylene and polyglycol diacrylate hydrogel
In example 4, the pretreatment method for the expanded polytetrafluoroethylene membrane was the same as in example 1, except that the preparation of the hydrogel, that is, step (4), was different.
(4) Compounding: the plasma activated and PVP grafted base membrane was transferred to a hydrogel preparation jig. A0.5 mol/L hydroxyethyl methacrylate solution was prepared, and an initiator a-glutaric acid (concentration: 0.1 mol% based on the monomer concentration) was added thereto. And introducing nitrogen into the solution to remove oxygen, transferring the solution into a mold with a base film, and irradiating for 12 hours under 365nm ultraviolet light. Taking out and soaking in deionized water for 24h, and replacing the deionized water for three times during the soaking period to prepare the composite hydrogel.
(5) And (3) post-treatment: coating polyacrylate pressure-sensitive adhesive on the edge position which is not covered with hydrogel, attaching release paper, and shearing to obtain the required wound composite dressing.
Example 5: compounding expanded polytetrafluoroethylene and polymethyleneacrylamide hydrogel
In example 5, the pretreatment method for the expanded polytetrafluoroethylene membrane was the same as in example 1, except that the preparation of the hydrogel, that is, step (4), was different.
(4) Compounding: the plasma activated and PVP grafted base membrane was transferred to a hydrogel preparation jig. A methylene acrylamide solution having a concentration of 0.5 mol/L was prepared, and an initiator a-glutaric acid (having a concentration of 0.1 mol% based on the monomer concentration) was added thereto. And introducing nitrogen into the solution to remove oxygen, transferring the solution into a mold with a base film, and irradiating for 12 hours under 365nm ultraviolet light. Taking out and soaking in deionized water for 24h, and replacing the deionized water for three times during the soaking period to prepare the composite hydrogel.
(5) And (3) post-treatment: coating polyacrylate pressure-sensitive adhesive on the edge position which is not covered with hydrogel, attaching release paper, and shearing to obtain the required wound composite dressing.
The preparation methods of the embodiments 6 to 9 are the same as those of the embodiment 1, except that the pore sizes of the expanded polytetrafluoroethylene films are different, and the pore sizes of the prepared composite dressings are different. The composite dressings prepared in examples 1 to 9 were measured according to the national standard contact wound dressing test method (part 2: water vapor transmission rate of breathable film dressing) (YYT 0471.2-2004), and the contact angle of the surface of the composite dressing was measured using a contact angle instrument, and the hydrogel thickness swelling rate was measured under water immersion.
TABLE 2 Performance parameters of composite dressings prepared in examples 1-9
Examples | Air permeability (g.m)-2·24h-1) | Ability to absorb seepage (g.100 cm)-2) | Contact angle (°) | Hydrogel thickness expansion ratio (%) under water immersion |
Example 1 | 6500 | 20 | 135 | <5 |
Example 2 | 10000 | 40 | 132 | <5 |
Example 3 | 6500 | 85 | 130 | <10 |
Example 4 | 9500 | 70 | 136 | <10 |
Example 5 | 9300 | 35 | 135 | <10 |
Example 6 | 6400 | 21 | 131 | <10 |
Example 7 | 6500 | 19 | 131 | <10 |
Example 8 | 6700 | 22 | 131 | <10 |
Example 9 | 6600 | 21 | 131 | <10 |
The photograph of the prepared wound dressing is shown in fig. 2, the contact angle of the surface of the dressing tested by using a contact angle meter is shown in fig. 3, and as can be seen from table 2, the contact angle of the outer side surface of the composite dressing prepared in examples 1-9 to water is as high as 135 degrees, the hydrophobic property of the polytetrafluoroethylene film is maintained, and the outer side surface of the composite dressing has excellent waterproof and antifouling properties. Meanwhile, the air permeability is 6500-10000 g.m-2·24h-1And has excellent air permeability.
The above examples of the present invention are merely illustrative of the present invention and are not intended to limit the embodiments of the present invention. Variations and modifications in other variations will occur to those skilled in the art upon reading the foregoing description. Not all embodiments are exhaustive. All obvious changes and modifications of the present invention are within the scope of the present invention.
Claims (9)
1. A high-strength waterproof breathable composite dressing comprises an outer layer and an inner layer, wherein the outer layer is a polytetrafluoroethylene film, and the inner layer is hydrogel;
the composite dressing is obtained by the following method:
(1) and (3) activation: selecting a polytetrafluoroethylene film with a pore structure, cutting, activating for 10-300 s by using a vacuum plasma cleaning machine, adjusting the flow of plasma gas to 10-100 mL/min, and controlling a vacuum system to keep the vacuum degree at 0.01-0.1 MPa to obtain an activated base film;
(2) grafting: putting the activated base membrane into an aqueous solution containing a hydrophilic high molecular compound, introducing nitrogen for 5-10 min to remove oxygen, and irradiating the surface of one side of the activated base membrane soaked in the aqueous solution for 5-10 h by using an ultraviolet lamp;
(3) cleaning: transferring the base film treated in the step (2) into deionized water for soaking for 12-48 h, replacing the deionized water for three times during soaking, and washing away unreacted compounds on the surface of the base film;
(4) compounding: transferring the base membrane treated in the step (3) into a clamp, sequentially adding raw materials of hydrogel into a mold in the clamp, and synthesizing and growing the hydrogel on the surface of one side of the activated base membrane grafted with the hydrophilic macromolecules to be compounded with the base membrane;
(5) and (3) post-treatment: taking out the base film after the hydrogel is cured, coating pressure-sensitive adhesive on the blank area around the hydrogel on the base film, pasting isolation paper on the back of the base film, and sealing and packaging to obtain the composite dressing.
2. The composite dressing of claim 1, wherein the polytetrafluoroethylene film is expanded and biaxially oriented, and the average pore diameter of the pore structure of the polytetrafluoroethylene film is less than 0.5 μm.
3. The composite dressing of claim 1, wherein the polytetrafluoroethylene film has a porosity of greater than 90% and a thickness of 20-500 μm.
4. The composite dressing of claim 1, wherein the hydrogel comprises a PVA hydrogel, a hydroxyethyl methacrylate hydrogel, a polymethacrylic acid hydrogel, or a polyethylene glycol diacrylate hydrogel.
5. The composite dressing of claim 1, wherein the hydrophilic polymer compound comprises acrylamide, methylene acrylamide, acrylic acid, methacrylic acid, vinyl pyrrolidone, or methacrylate compounds.
6. The composite dressing of claim 1, wherein the concentration of the hydrophilic polymer compound in the aqueous solution of the hydrophilic polymer compound in step (2) is 0.2-5 mol/L.
7. The composite dressing of claim 1, wherein the hydrogel is prepared from one or more monomers selected from acrylamide, methylene acrylamide, acrylic acid, methacrylic acid, and hydroxyethyl methacrylate; or the raw material for preparing the hydrogel is one or more of a plurality of high molecular compounds of hyaluronic acid, polyvinyl alcohol or polyethylene glycol diacrylate.
8. The composite dressing of claim 1, wherein the hydrogel is synthesized from small molecule monomers by free radical reaction under the action of a cross-linking agent and an initiator.
9. The composite dressing of claim 1, wherein the hydrogel is prepared by physical or chemical crosslinking of a polymer compound.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010394009.0A CN111513925B (en) | 2020-05-11 | 2020-05-11 | High-strength waterproof breathable composite dressing and preparation method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010394009.0A CN111513925B (en) | 2020-05-11 | 2020-05-11 | High-strength waterproof breathable composite dressing and preparation method thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CN111513925A CN111513925A (en) | 2020-08-11 |
CN111513925B true CN111513925B (en) | 2021-10-08 |
Family
ID=71907993
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202010394009.0A Active CN111513925B (en) | 2020-05-11 | 2020-05-11 | High-strength waterproof breathable composite dressing and preparation method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN111513925B (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114468460A (en) * | 2020-10-26 | 2022-05-13 | 南京机电职业技术学院 | Antibiotic ventilative sports shoes |
CN113181422A (en) * | 2021-05-18 | 2021-07-30 | 四川轻化工大学 | Antibacterial nontoxic hydrogel dressing and preparation method thereof |
EP4186532B1 (en) | 2021-11-29 | 2024-04-10 | Asetreat GmbH & Co.KG | Electret-based wound dressing |
CN114471193B (en) * | 2022-03-07 | 2022-11-25 | 四川轻化工大学 | Filtering membrane with ultraviolet-resistant self-cleaning function and application thereof |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101091028B1 (en) * | 2009-07-02 | 2011-12-09 | 아주대학교산학협력단 | In situ forming hydrogel and biomedical use thereof |
CN105086318B (en) * | 2015-08-29 | 2018-05-18 | 北京诺康达医药科技有限公司 | A kind of antibacterial transparent dressing and its preparation method and application |
CN105664238B (en) * | 2016-02-25 | 2018-10-30 | 天津大学 | A kind of preparation method and application of amphoteric ion aerogel dressing |
CN106075734A (en) * | 2016-08-17 | 2016-11-09 | 山西康灵医疗器械有限公司 | Apply core and magnet therapeutic plaster |
CN208301796U (en) * | 2017-09-29 | 2019-01-01 | 明基材料(芜湖)有限公司 | Negative pressure wound dressings |
CN108117662B (en) * | 2017-11-30 | 2020-07-21 | 中国科学院兰州化学物理研究所 | Method for preparing hydrophilic lubricating coating on surface of material |
CN108210992A (en) * | 2018-01-30 | 2018-06-29 | 张思东 | A kind of preparation method of the medical aquogel eluted and its aerogel dressing |
CN208808836U (en) * | 2018-03-12 | 2019-05-03 | 纪莉 | A kind of medical hydrogel dressings with Improvement type protective film layer |
CN109966539A (en) * | 2019-04-11 | 2019-07-05 | 中原工学院 | A kind of preparation method of low adherency wound dressing |
-
2020
- 2020-05-11 CN CN202010394009.0A patent/CN111513925B/en active Active
Also Published As
Publication number | Publication date |
---|---|
CN111513925A (en) | 2020-08-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN111513925B (en) | High-strength waterproof breathable composite dressing and preparation method thereof | |
US20200214899A1 (en) | Superabsorbent laminate dressing | |
AU631475B2 (en) | Membranes for absorbent packets | |
CN108175573B (en) | Hydrophilic-hydrophobic composite wound dressing for directionally leading out biological fluid and preparation method and application thereof | |
CN106729927B (en) | Modified bioactive glass/polyacrylamide/oxidized sodium alginate hydrogel dressing and preparation method thereof | |
JPH03175981A (en) | Porous membrane having hydrophillic surface for accelerating cell growth and method of its production | |
JPH02229839A (en) | Hydrophilic material and production thereof | |
CN111588900B (en) | Waterproof breathable high-elastic self-repairing double-layer nanofiber membrane for skin dressing and preparation method thereof | |
Al-Jumaili et al. | Plasma treatment of polymeric membranes | |
CN102086592A (en) | Polymeric hydrogel grafted on fibers by calcium ion crosslinking and preparation method thereof | |
CN111558081B (en) | Method for preparing tannin modified double-layer hydrogel | |
CN101497002A (en) | Method for preparing anti-pollution chitosan-nonwoven cloth composite porous filter membrane | |
WO2011153085A2 (en) | Process for making coated porous materials | |
WO2015103988A1 (en) | Medical dressing hydrogel composite fabric, and preparation method therefor and uses thereof | |
CN104906623A (en) | Cellulose-based dressing and preparation method and application thereof | |
Goushki et al. | Free radical graft polymerization of 2-hydroxyethyl methacrylate and acrylic acid on the polysulfone membrane surface through circulation of reaction media to improve its performance and hemocompatibility properties | |
CN109675134A (en) | A kind of anticoagulant method of modifying of haemodialyser and its application | |
JP6464866B2 (en) | Surface-modified substrate, polymer-coated substrate, and production method thereof | |
CN1304096C (en) | Method for hydrophilic modification of ultrahigh molecular weight polyethylene microporous membrane surface | |
CN114306714A (en) | Method for using stem cell composite biological material for skin regeneration and repair | |
CN103611430A (en) | Production method for high-ion selectivity hollow fibrous nanofiltration membrane | |
EP0566754B1 (en) | Heat-resisting porous membrane, hydrophilized heat-resisting porous membrane and production processes thereof | |
CN115569521A (en) | Cellulose composite ultrafiltration membrane and preparation method thereof | |
Yin et al. | Mussel-inspired modification of microporous polypropylene membranes for functional catalytic degradation | |
US20040081817A1 (en) | Absorbent material and absorbent article |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |